• BSE
  • NSE
    • {{d.cmpname}}
    • {{d.price}}
    • ({{d.PerChg}}%)
Equity | News | Hot Pursuit
Hot Pursuit
Vivimed Labs soars on regulatory nod for three products
(15:40, 16 Apr 2021)

The first approval is for Bilastine tablets 20mg under brand name 'FLUSTIN'. Bilastine is a second-generation antihistamine. The drug is used in the treatment of allergic rhino conjunctivitis and urticaria (hives).

The second approval is for Ornidazole and Otloxacin tablets under brand name 'ORZOLE COMBI'. Ornidazole 500mg + Ofloxacin 200mg tablets is used in the treatment of bacterial and parasitic infections. It is used to treat gastrointestinal infections such as acute diarrhoea or dysentery, gynaecological infections, lung infections and urinary infections.

The third approval is for Paracetamol 125mg/5ml and Chlorpheniramine Maleate Syrup 2mg/5ml 100ml under brand name 'FEBRIL'.

Paracetamol, also known as acetaminophen, is a medication used to treat fever and mild to moderate pain. Chlorpheniramine Maleate is an antihistamine used to treat the symptoms of allergic conditions such as allergic rhinitis. Menthol is a topical analgesic. It works by temporarily relieving minor pain.

Commenting on the approvals, Ramesh Krishnamurthy, CEO of Vivimed Labs, said: These 3 approvals are testimony to high quality team work of Vivimed 's end to end team. Branded exports is strategic thrust of 'New and Vibrant Vivimed'. The approvals are testimony to Vivimed 's growth strategy.

Vivimed Labs is a pharmaceutical and chemical products company. The company's segments include speciality chemicals and pharmaceuticals.

On a consolidated basis, Vivimed Labs posted a net loss of Rs 49.55 crore in Q3 FY21 as against a net loss of Rs 32.07 crore in Q3 FY20. Net sales jumped 40.6% year on year to Rs 277.94 crore in Q3 FY21.

Powered by Capital Market - Live News

.
Stock Broker Name Registration Number Registered Address Branch Address Contact Number Email id
DB (International) Stock Brokers Limited INZ000179035 (BROKING)

IN-DP-CDSL-266-2004 (DEPOSITORY)
Unit No. 210/211/211A at 2nd floor, Dalal Street Commercial Cooperative Society Ltd, Block No.53, Zone 5, Gift City, Gandhinagar, Gujarat-382355 Head Office – 114, New Delhi House, 27 Barakhamba Road, Delhi 110001 011-43606162 compliance@dbonline.in
51, Mini Market T/F Mandir Wali Gali, Yusuf Sarai, New Delhi 110016 011-35936102 greenpark@dbonline.in
C-12, DB Plaza, RDC Raj Nagar, Ghaziabad 2012002 0120-4150393 ghaziabad@dbonle.in
827, Tower B3, Spaze I Tech Park, Sector 49, Sohna Road, Gurgaon, Haryana – 122001 0124-4383584 sanjay05@dbonline.in
Plot No 4, Wasme House, Film City Sector 16A, Noida – 201301 0120-4823200 compliance@dbonline.in
Out Side Jassusar Gate, Bikaner, Rajasthan – 334001 9001643408 bikaner@dbonline.in
Office No 101, City Center, Opp. High Court, M G Road, Indore 452001 9424083019 brajeshsadani@dbonline.in
203, Marshal House 25, Strand Road, Kolkata 700001 033-40055270 b032@dbonline.in
Shop No.-7, 2nd Floor, Amar Complex, Opp. Hanumaan Mandir, The Mall, Solan- 173212 6230604596 parwanoo@dbonline.in
Daga Commodities Private Limited INZ000028833 114, New Delhi House, 27 Barakhamba Road Delhi New Delhi DL 110001- 0120-4823200 compliance@dbonline.in
DAGA BUSINESS (INTERNATIONAL) STOCK BROKERS IFSC PRIVATE LIMITED - Unit No. 228, Signature Building, Second Floor, Block 13B, Zone-1, GIFT SEZ, Gandhinagar,Gujarat 382355 - 0120-4823200 compliance@dbonline.in
Investor Grievances Email ID: investors@dbonline.in
Copyright © 2016 All rights Reserved DB (International) Stock Brokers Ltd.     Designed, Developed and content powered by C-MOTS Infotech( ISO 9001:2015 certified )
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."         "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors."          "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Attention Investors ::
subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries | Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 01, 2020. | Update your email id and mobile number with your stock broker / depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors"